Elicio Therapeutics stockholders elect two directors, ratify auditor at annual meeting

Elicio Therapeutics, Inc.

Karen J. Wilson elected with 8,588,077 votes for, 420,412 against; 2,154,961 broker non-votes.
Robert R. Ruffolo Jr. elected with 8,980,091 votes for, 28,388 against; 2,154,961 broker non-votes.
Baker Tilly US, LLP ratified as auditor for FY2025 with 11,133,552 votes for, 29,923 against.
Quorum of 70.1% achieved with 11,172,771 shares voted.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.